Research ExplorerPublicationsPreliminary recommendations of the German Society of Rheumat...

Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic

Standard

Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic. / Schulze-Koops, Hendrik; Specker, Christof; Iking-Konert, Christof; Holle, Julia; Moosig, Frank; Krueger, Klaus.

In: ANN RHEUM DIS, Vol. 79, No. 6, 06.2020, p. 840-842.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Schulze-Koops, H, Specker, C, Iking-Konert, C, Holle, J, Moosig, F & Krueger, K 2020, 'Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic', ANN RHEUM DIS, vol. 79, no. 6, pp. 840-842. https://doi.org/10.1136/annrheumdis-2020-217628

APA

Schulze-Koops, H., Specker, C., Iking-Konert, C., Holle, J., Moosig, F., & Krueger, K. (2020). Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic. ANN RHEUM DIS, 79(6), 840-842. https://doi.org/10.1136/annrheumdis-2020-217628

Vancouver

Schulze-Koops H, Specker C, Iking-Konert C, Holle J, Moosig F, Krueger K. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic. ANN RHEUM DIS. 2020 Jun;79(6):840-842. https://doi.org/10.1136/annrheumdis-2020-217628

Bibtex

@article{6dbec2ec5ac4462cbd594ac871adcb58,
title = "Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic",
keywords = "Antirheumatic Agents/therapeutic use, Betacoronavirus, COVID-19, Coronavirus Infections/complications, Humans, Infections, Pandemics, Pneumonia, Viral/complications, Rheumatic Diseases/complications, Rheumatology, Risk Factors, SARS-CoV-2",
author = "Hendrik Schulze-Koops and Christof Specker and Christof Iking-Konert and Julia Holle and Frank Moosig and Klaus Krueger",
note = "Letter",
year = "2020",
month = jun,
doi = "10.1136/annrheumdis-2020-217628",
language = "English",
volume = "79",
pages = "840--842",
journal = "ANN RHEUM DIS",
issn = "0003-4967",
publisher = "BMJ PUBLISHING GROUP",
number = "6",

}

RIS

TY - JOUR

T1 - Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic

AU - Schulze-Koops, Hendrik

AU - Specker, Christof

AU - Iking-Konert, Christof

AU - Holle, Julia

AU - Moosig, Frank

AU - Krueger, Klaus

N1 - Letter

PY - 2020/6

Y1 - 2020/6

KW - Antirheumatic Agents/therapeutic use

KW - Betacoronavirus

KW - COVID-19

KW - Coronavirus Infections/complications

KW - Humans

KW - Infections

KW - Pandemics

KW - Pneumonia, Viral/complications

KW - Rheumatic Diseases/complications

KW - Rheumatology

KW - Risk Factors

KW - SARS-CoV-2

U2 - 10.1136/annrheumdis-2020-217628

DO - 10.1136/annrheumdis-2020-217628

M3 - Other (editorial matter etc.)

C2 - 32345619

VL - 79

SP - 840

EP - 842

JO - ANN RHEUM DIS

JF - ANN RHEUM DIS

SN - 0003-4967

IS - 6

ER -